Immunomedics Inc. (IMMU) Income Statement

Income Statement for Immunomedics Inc.  (IMMU) 
$ 3.68   -0.02 (-0.54%) Volume: 268.53 k 4:00 PM EST Feb 10, 2012
Statement: View:
Income [+] in Thousands of Dollars
06/2011 06/2010 06/2009 06/2008 06/2007
Operating Revenue 14,709 60,930 30,021 3,651 8,506
Total Revenue 14,709 60,930 30,021 3,651 8,506
Adjustments to Revenue - - - - -
Cost of Revenue 938 (45,676) (24,649) 1,115 (3,952)
Cost of Sales With Depreciation 419 960 284 444 599
Gross Margin 15,648 15,254 5,372 4,766 4,554
Gross Operating Profit 15,648 15,254 5,372 4,766 4,554
Selling/General/Admin Expense (7,944) (6,183) (5,770) (4,037) (3,767)
Research & Development (25,369) (19,854) (21,485) (22,209) (19,841)
Advertising - - - - -
EBITDA (Operating Income Before Depreciation) (17,665) (10,783) (21,883) (21,480) (19,054)
Depreciation & Amortization (1,358) 44,716 24,365 (1,559) 3,353
Depreciation, Unreconciled - - - - -
Amortization - - - - -
Amortization of Intangibles - - - - -
Operating Income (19,023) 33,933 2,482 (23,039) (15,702)
Operating Profit After Depreciation (19,023) 33,933 2,482 (23,039) (15,702)
Interest Income 519 789 1,181 2,257 1,741
Earnings from Equity Interest - - - - -
Other Income, Net 3,369 1,045 (2,284) 121 35
Income, Acquired in Process R&D - - - - -
Income, Restructuring and M&A - - - - -
Other Special Charges - - - (2,950) -
Total Income Before Interest Expense (EBIT) (15,135) 35,767 1,380 (23,611) (13,925)
Interest Expense - - (6) (65) (3,234)
Income Before Tax (15,135) 35,767 1,373 (23,676) (17,159)
Income Taxes (110) 1,229 900 690 397
Minority Interest 174 - - 76 106
Preferred Securities of Subsidiary Trust - - - - -
Other Special Charges (15,135) 35,767 1,373 (23,599) (17,053)
Net Income from Continuing Operations (15,070) 36,996 2,274 (22,909) (16,656)
Net Income from Discontinued Operations - - - - -
Net Income from Total Operations (15,070) 36,996 2,274 (22,909) (16,656)
Normalized Income (15,070) 36,996 2,274 (19,959) (16,656)
Extraordinary Income/Loss - - - - -
Special Income/Charges - - - (2,950) -
Income from Cum. Effect of Acct Change - - - - -
Income from Tax Loss Carryforward - - - - -
Net Income Available for Common (15,070) 36,996 2,274 (22,909) (16,656)
Other Gains - - - - -
Total Net Income (15,070) 36,996 2,274 (22,909) (16,656)
Net Income Available for Common (15,070) 36,996 2,274 (22,909) (16,656)
Results [+] in Dollars (Preferred Dividends in Thousands)
06/2011 06/2010 06/2009 06/2008 06/2007
Dividends Paid Per Share 0.00 0.00 0.00 0.00 0.00
Preferred Dividends - - - - -
Basic EPS from Continuing Operations -0.20 0.49 0.03 -0.31 -0.26
Basic EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Basic EPS from Extraordinary Income Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Basic EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Total Net Income -0.20 0.49 0.03 -0.31 -0.26
Basic Normalized Net Income per Share -0.20 0.49 0.03 -0.27 -0.26
Basic EPS from Total Operations -0.20 0.49 0.03 -0.31 -0.26
Diluted EPS from Continuing Operations -0.20 0.49 0.03 -0.31 -0.26
Diluted EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Extraordinary Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Total Net Income -0.20 0.49 0.03 -0.31 -0.26
Diluted Normalized Net Income per Share -0.20 0.49 0.03 -0.27 -0.26
Excise Tax - - - - -
Diluted EPS from Total Operations -0.20 0.49 0.03 -0.31 -0.26